🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of orelabr...
Status
Unknown
Location
The first affiliated hospital of bengbu medical college
Start Date
2022-11-02
Trial ID
NCT05234684
Treatments Being Tested
Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomi...
Status
Recruiting
Location
Arizona Neuroscience Research, LLC
Start Date
2026-03-23
Trial ID
NCT07299019
Treatments Being Tested
Compare the efficacy and safety of Orelabrutinib plus bendamustine+ rituxim...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2024-05-29
Trial ID
NCT06363994
Treatments Being Tested
The purpose of the study is to assess the Safety, Tolerability, PK/PD and p...
Status
Completed
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-07-09
Trial ID
NCT04305197
Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomi...
Status
Recruiting
Location
Arizona Neuroscience Research, LLC
Start Date
2026-03-23
Trial ID
NCT07067463
Treatments Being Tested
This is a randomized controlled study of high-dose Dexamethasone combined w...
Status
Recruiting
Location
Qilu Hospital of Shandong University
Start Date
2026-04-08
Trial ID
NCT07559331
This is a phase IIb, randomized, double-blind, placebo-controlled, multicen...
Status
Recruiting
Location
The first affiliated hospital of bengbu medical college
Start Date
2023-04-29
Trial ID
NCT05688696
Treatments Being Tested
A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to ...
Status
Unknown
Location
The first affiliated hospital of bengbu medical college
Start Date
2023-10-26
Trial ID
NCT06004856
Treatments Being Tested
This is A Randomized, Blinded, Placebo- and Positive-Controlled, Four-Perio...
Status
Unknown
Location
Beijing GoBroad Boren Hospital
Start Date
2022-11-19
Trial ID
NCT05660720
This is a randomized, double-Blind, placebo-controlled Phase 2 Study of Ore...
Status
Unknown
Location
Neurology Associates of Ormond Beach
Start Date
2021-03-01
Trial ID
NCT04711148
Treatments Being Tested